Evidence map›Paper›PMID 26034815›Full record

ArticleJournal of the American Chemical Society2015

A synthesis of alsmaphorazine B demonstrates the chemical feasibility of a new biogenetic hypothesis.

Allen Y Hong, Christopher D Vanderwal

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
9.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Intramolecular N-O Bond Formation for the Synthesis ofJournal of the American Chemical Society · 2025
    Article
  3. Heterocyclic Surgery for Isotopic Labeling.Synlett : accounts and rapid communications in synthetic organic chemistry · 2025
    Article
  4. Article
  5. Synthesis ofOrganic letters · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Allen Y HongDepartment of Chemistry, University of California, Irvine, 1102 Natural Sciences II, Irvine, California 92697-2025, United States.
Christopher D VanderwalDepartment of Chemistry, University of California, Irvine, 1102 Natural Sciences II, Irvine, California 92697-2025, United States.
University of California, Irvine · US

Funding

Total Synthesis of Alsmaphorazine A, an Alkaloid Natural Product Inhibitor of NitF32GM103058 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI HONG, ALLEN Y. · 2012 to 2015
$142k
NIGMS NIH HHS F32 GM103058
6 · The paper itself

Abstract

An N-oxide fragmentation/hydroxylamine oxidation/intramolecular 1,3-dipolar cycloaddition cascade efficiently converted an oxidized congener of akuammicine into the complex, hexacyclic architecture of the alsmaphorazine alkaloids. This dramatic structural change shows the chemical feasibility of our novel proposal for alsmaphorazine biogenesis. Critical to these endeavors was a marked improvement in our previously reported Zincke aldehyde cycloaddition approach to indole alkaloids, which permitted the gram-scale synthesis of akuammicine. The chemoselective oxidations of akuammicine leading up to the key rearrangement also generated several biogenetically related alkaloids of the alstolucine and alpneumine families.

Indexed as

CyclizationIndole AlkaloidsModels, MolecularMolecular StructureOxidation-Reductionalsmaphorazine BIndole Alkaloids

Identifiers

PMID26034815
PMCPMC4477012
OpenAlexW2394288389

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.